A. Machelle Sanders
Independent DirectorMs. A. Machelle Sanders is Director of Fortrea Holdings Inc. since May 14, 2024. She served as Director at Radius Health, Inc. since January 04, 2021 until August 10, 2022. Ms. Sanders serves as an Independent Director at BioCryst Pharmaceuticals, Inc. since February 2022. She had been an Independent Director of NVN Liquidation, Inc. (formerly known as Novan, Inc.) since September 26, 2017 until April 2024. She serves as the North Carolina Secretary of Commerce, a position she has held since February 2021. Ms. Sanders has pharmaceutical and biotechnology experience with increasing levels of quality assurance and manufacturing operations responsibilities with Biogen, Inc. (“Biogen”) and AkzoNobel. Most recently, she led product operations for Biogen’s multiple sclerosis franchise as its Vice President of Multiple Sclerosis Franchise Product Operations and prior to that, she was Vice President of Manufacturing and General Manager for Biogen’s largest global manufacturing operation. Ms. Sanders served as Secretary of the North Carolina Department of Administration from January 2017 to February 2021. She held the title of vice president of manufacturing and general manager of the company's largest and most advanced manufacturing facility in Research Triangle Park, North Carolina. As Administration Secretary, Ms. Sanders overseen the state agency whose mission is to provide high quality services effectively, efficiently and economically to its customers: the citizens, agencies and communities of North Carolina. She provides leadership for staff support to several councils and commissions which advocate for the special needs of North Carolina's citizens. Ms. Sanders is a seasoned executive with progressive pharmaceutical and biotechnology experience. In the private sector, Ms. Sanders was responsible for the pharmaceutical operations and technology operational strategy for Biogen's multiple sclerosis (MS) franchise (i.e., AVONEX, PLEGRIDY, TECFIDERA and TYSABRI). She served as Vice President of Manufacturing and General Manager of Biogen from 2009 to 2015. Ms. Sanders has held leadership positions in manufacturing, global quality assurance and quality control at Biogen, Inc., Purdue Pharmaceuticals and Diosynth Akzo Nobel. She is the Secretary of the State of North Carolina Department of Commerce since February 2021. She holds a Bachelor of Science degree in Biochemistry from North Carolina State University and a Master of Health Administration (MHA) from Pfeiffer University.
Positions
- Company NameBioCryst Pharmaceuticals, Inc.Stock CodeBCRXPositionIndependent DirectorColleagues
- CKCharles K. GayerCEO, President & Director
- VJVincent J. MilanoIndependent Chairman
- BGBabar GhiasCFO & Head of Corporate Development
- APAlane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary
- JRJohn RueschChief Technical Operations Officer
- DWDavid W. JenkinsChief Scientific Officer
- AGAlan G. LevinIndependent Director
- SKSteven K. GalsonIndependent Director
- Company NameFortrea Holdings Inc.Stock CodeFTREPositionIndependent DirectorColleagues
- ATAnshul ThakralCEO & Director
- PMPeter M. NeupertChairman of the Board & Lead Independent Director
- MAMark A. MoraisCOO & President of Clinical Services
- JMJill McConnellExecutive Officer
- DVDrayton VirklerPresident & Chief Commercial Officer
- JFJason F. KnoblauchChief Financial Officer
- ARAmrit RayIndependent Director
- AMA. Machelle SandersIndependent Director
- DRDavid Ross SmithIndependent Director
